Liver Cancer Trial, Recruiting NCT07305428 Sponsor: The University of Hong Kong Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT07305428
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with liver cancer (hepatocellular carcinoma/HCC) based on specific imaging scans (CT or MRI) showing a liver nodule larger than 1cm with particular patterns, and you have either liver scarring (cirrhosis) or chronic hepatitis B infection
  • Your liver tumor(s) are between 5 and 25 cm in size, or you have 3 or fewer tumors, or there is involvement of a branch of the main blood vessel feeding the liver (confirm with trial site)
  • You are between 18 and 80 years old
  • Your liver is functioning at a certain level, rated as Child-Pugh class A or B7 (a score doctors use to measure liver health — confirm with trial site)
  • You are able to carry out normal daily activities with little or no limitation, rated 0 or 1 on a standard activity scale used by doctors

Who may not be able to join:

  • You have had, or currently have, another type of cancer that has spread into surrounding tissue
  • You have previously had radiation treatment to your liver area, including a specific internal radiation therapy
  • You have a serious, currently active other illness or health condition
  • Your cancer has spread to areas outside the liver
  • You have a blood clot or tumor involvement in the main portal vein (a major blood vessel to the liver) or the large vein that carries blood to the heart
  • You currently have a build-up of fluid in your abdomen (ascites) or confusion related to liver disease (encephalopathy)
  • Your situation does not meet the specific requirements for the radiation treatment used in this trial, including: any single liver tumor larger than 15 cm, all tumors added together measuring more than 25 cm, more than 3 separate liver tumors, or the tumor is growing directly into nearby digestive organs or major bile ducts

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +852 2255 6646

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 April 2019
Est. completion
31 December 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

rate of successive tumour downstaging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov